Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in ...

SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in ...

Next-Gen Oncology Drugs Set New Standards in Cancer TreatmentThe Global Cancer/Oncology Drugs Market is valued at USD 183.4 ...

Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...

Swathi Kulkarni, Managing Director, India, and Tom Halliday, Chief Commercial Officer bring decades of global, healthcare and life sciences technology experience, strengthening Konovo’s ability to ...

CAMAS, Wash.--(BUSINESS WIRE)--nLIGHT, Inc. (Nasdaq: LASR), a leading provider of high-power lasers for mission critical directed energy, optical sensing, and advanced manufacturing applications, ...

Kharabi led development of CD19 CAR-T therapy TECARTUS®; brings extensive cell and gene therapy expertise to guide 3T’s bispecific T-cell engager programs into the clinicKnudsen oversees more than 100 ...

If you're living with IgA nephropathy (IgAN), you know the weight it carries—the constant worry about your kidneys, the fatigue from proteinuria, and the fear of progressing to dialysis or a ...

Collaboration leverages Cartography’s cutting-edge ATLAS and SUMMIT platforms to identify tumor-selective antigens; Pfizer to lead therapeutic development –– Cartography to receive upfront, near-term ...

OncoNano Medicine, Inc. (“OncoNano”) today announced a research collaboration with Gilead Sciences, Inc. (Nasdaq: GILD) (“Gilead”) to evaluate OncoNano’s ON-BOARD™ encapsulation technology with Gilead ...

Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric disorders, today announced that the first participant has been dosed in the ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic ...